Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Phar

0.00

0.00 (0.00)%

NSE

BSE

Financial Strength

Stable

Ratios Analysis

Balance Sheet

Results Analysis

Cash Flow

Profit Loss

Key Metrics

Market Capitalisation
58609.41 Cr.
Enterprise Value
57209 Cr.

Shares Outstanding

16.94 Cr.

Dividend Yield

1.56%

Face Value

10

Book Value

115.94

TTM EPS

54.25 Cr.

TTM-PE

63.77

Latest Equity

169.41

Latest Reserve

1795

Peers Comparison

StocksCMP (₹)Mark. Cap SizeP/EP/BEPSROE
LupinLoading...Mid-cap68.542.399.453.68
Sun Pharma Inds.Loading...Large-cap136.0316.4111.9112.05
Ipca LaboratoriesLoading...Mid-cap57.394.9621.578.7
Abbott IndiaLoading...Mid-cap49.4314.92446.7832.07
CiplaLoading...Large-cap32.494.324614.14
Torrent PharmaLoading...Large-cap41.798.436.7920.5
Zydus LifesciencesLoading...Large-cap25.372.8419.3711.6
PfizerLoading...Small-cap25.44.94136.3820.55
Dr. Reddy’s LabLoading...Large-cap18.413.65334.4121.76
Divi’s LabLoading...Large-cap41.145.8868.6914.89
Ajanta PharmaLoading...Small-cap25.894.4946.717.68
Glenmark PharmaLoading...Mid-cap44.141.3910.534.07
Enrich money logo